Nano Holdings, Inc. (TYO:4571)
Japan · Delayed Price · Currency is JPY 179.00
+2.00 (1.13%)
At close: Mar 6, 2026
Nano Holdings Revenue
Nano Holdings had revenue of 89.00M JPY in the quarter ending December 31, 2025, with 17.11% growth. This brings the company's revenue in the last twelve months to 155.00M, up 35.96% year-over-year. In the fiscal year ending March 31, 2025, Nano Holdings had annual revenue of 108.00M, down -20.00%.
Revenue (ttm)
155.00M
Revenue Growth
+35.96%
P/S Ratio
88.10
Revenue / Employee
7.75M
Employees
20
Market Cap
13.66B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 108.00M | -27.00M | -20.00% |
| Mar 31, 2024 | 135.00M | -67.00M | -33.17% |
| Mar 31, 2023 | 202.00M | 84.18M | 71.45% |
| Mar 31, 2010 | 117.82M | -235.83M | -66.68% |
| Mar 31, 2009 | 353.65M | 90.93M | 34.61% |
| Mar 31, 2008 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2007 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2006 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Kidswell Bio | 7.06B |
| RaQualia Pharma | 3.98B |
| StemCell Institute | 2.78B |
| ReproCELL | 2.52B |
| Immuno-Biological Laboratories | 1.03B |
| Stella Pharma | 968.00M |
| CellSeed | 161.00M |
| Kubota Pharmaceutical Holdings | 21.34M |